Slower digestion often means stool moves more slowly, leading to bloating, discomfort and fewer bowel movements
Advances in Imaging of Lymph Flow Disorders
In December 2025, the Food and Drug Administration (FDA) approved an oral pill form of Wegovy for weight loss, and in April 2026 approved the once-daily oral GLP-1 drug Foundayo (orforglipron) also for weight loss
Additionally, 40.4% of participants using CagriSema lost 25% or more of their body weight, compared to just 16.2% with semaglutide, 6.0% with cagrilintide, and less than 1% with placebo
In: Srivastava V (ed) Peptide Therapeutics: Strategy and Tactics for Chemistry, Manufacturing, and Controls
Reference: Neelakantan H, Vance V, Wetzel MD, Wang HY, McHardy SF, Finnerty CC, Hommel JD, Watowich SJ (2018)